2017
DOI: 10.14301/llcs.v8i3.439
|View full text |Cite
|
Sign up to set email alerts
|

Integrating area-based and national samples in birth cohort studies: the case of Life Study

Abstract: The most recent UK birth cohort study, known as 'Life Study' was a longitudinal study planned to involve some 80,000 babies and comprised two components. The largest, the 'Pregnancy Component' was to consist of around 60,000 pregnant women who were to be recruited when attending for a routine antenatal ultrasound at selected maternity units in England. The other component, the 'Birth Component' was to be a random sample of intended size 20,000 live births across the UK. Recruitment to the cohort was to take pl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
(11 reference statements)
0
1
0
Order By: Relevance
“…'Life Study' comprised an innovative design of two integrated samples -a 'Pregnancy Component', purposively sampled from a small number of areas, and a nationally representative 'Birth Component', with multiple respondents and contacts in each (Dezateux, Knowles, et al, 2016;Goldstein, Sera, Elias, & Dezateux, 2017) (Table 1). Questionnaires were developed with input from clinicians, population, social and biomedical scientists, relevant stakeholders and experts, and in consultation with UK research and policy communities.…”
Section: Introductionmentioning
confidence: 99%
“…'Life Study' comprised an innovative design of two integrated samples -a 'Pregnancy Component', purposively sampled from a small number of areas, and a nationally representative 'Birth Component', with multiple respondents and contacts in each (Dezateux, Knowles, et al, 2016;Goldstein, Sera, Elias, & Dezateux, 2017) (Table 1). Questionnaires were developed with input from clinicians, population, social and biomedical scientists, relevant stakeholders and experts, and in consultation with UK research and policy communities.…”
Section: Introductionmentioning
confidence: 99%